Vaccines

Algae are bacteria-fight experts. Why aren’t we using them more for drug discovery?

What sparked fears and prompted an anti-vax movement in the Philippines?

Public health groups have helped boost interest in the underserved market of specialty vaccines.

The industry draws one step closer to creating a universal flu vaccine.

The solution to multiple drugs co-existing in a syringe may lie with microparticles

Steve Davis details some of the PATH's success stories in global health.

Steve Davis, President and CEO of PATH, and lecturer, Social Innovation, at Stanford University, California, USA.

We need more vaccine manufacturing techniques at our disposal.

We forge ahead to celebrate the fantastic individuals involved in bettering the pharma industry.

Can genetically engineered bacteria help alleviate cold chain issues for oral vaccines?